Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Living Cell Technologies reports results from phase I/IIa clinical trial of DiabeCell

Oct. 28, 2009

Phase I trial of recombinant human acid sphingomyelinase in type B Niemann-Pick disease reported

Oct. 27, 2009

New glucokinase activators described by Astellas Pharma as antidiabetic agents

Oct. 26, 2009

Dienogest exhibits favorable safety profile in the long-term treatment of endometriosis

Oct. 26, 2009

Merck KGaA describes glucokinase activators for the treatment of diabetes

Oct. 23, 2009

Isis reports results from phase II study of ISIS-113715 in type 2 diabetes

Oct. 23, 2009

Chugai and Taisho file NDA in Japan for eldecalcitol for osteoporosis

Oct. 23, 2009

Teijin signs exclusive sublicense agreement for TMX-67 with Ipsen and Menarini

Oct. 23, 2009

The GnRH antagonist TAK-38 has potential for the treatment of endometriosis

Oct. 23, 2009

AMR-MCH-14 reduces food intake and body fat in preclinical model of obesity

Oct. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...